Riskpilot← Back to searchSign inGet full accessSFBH Medicinkonsult AB
ABActiveOrg 5593821779Olof Skötkonungsgatan 66General medical practice activities · NACE 8621Est. 20221 employees
Revenue 2025
SEK 130K
-43% vs 2024
EBITDA margin
87.8%
-48% vs 2024
Equity ratio
77.0%
Financial strength
Net profit 2025
SEK 91K
-48% vs 2024
| Revenue | SEK 130K | -43% |
| EBITDA | SEK 114K | -48% |
| Net profit | SEK 91K | -48% |
| Total assets | SEK 154K | -43% |
| Equity | SEK 118K | -43% |
| Employees | 1 | — |
Legal name
SFBH Medicinkonsult AB
Org number
5593821779
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
23 maj 2022
Share capital
SEK 25 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bolaget skall syssla med konsultverksamhet inom vårdpersonalbemanning, medicinsk rådgivning och utbildning samt affärsverksamhet där medicinsk kompetens är tillämplig och därtill förenlig verksamhet. Handel med och förvaltning av värdepapper, fastigheter samt annan lös och fast egendom och därtill förenlig verksamhet.
Address
Olof Skötkonungsgatan 66
Email
sfbhmedicinkonsult@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue | 112 | 266 | 230 | 130 |
| Staff expenses | −1 | −0 | −1 | −0 |
| EBITDA | 97 | 250 | 219 | 114 |
| Depreciation & amort. | — | — | — | — |
| EBIT | 97 | 250 | 219 | 114 |
| Net financials | — | 0 | −0 | 0 |
| Profit before tax | 97 | 250 | 218 | 114 |
| Tax | −20 | −51 | −45 | −23 |
| Net profit | 76 | 198 | 173 | 91 |
| Item | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Total assets | 138 | 296 | 271 | 154 |
| Equity | 101 | 225 | 208 | 118 |
| Long-term debt | — | — | — | — |
| Short-term debt | 36 | 72 | 63 | 35 |
| Total debt | 36 | 72 | 63 | 35 |
EBITDA margin
87.8%
This company
15.8%
Market median
+456% vs market
20222025
Equity ratio
77.0%
This company
38.2%
Market median
+102% vs market
20222025
Return on equity
76.5%
This company
18.4%
Market median
+316% vs market
20222025
Net profit margin
69.7%
This company
8.1%
Market median
+760% vs market
20222025
Asset turnover
0.85×
This company
1.12×
Market median
+24% vs market
20222025
Debt / equity
0.30×
This company
0.62×
Market median
+52% vs market
20222025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-05-23 – 2022-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
| Former (3) | ||
| Deputy Board Member | 2022 – 2022 | |
| Deputy Board Member | 2022 – 2022 | |
| Board of Directors | 2022 – 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SFBH Medicinkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Felix Wiktor Lundin | Board of Directors | 0 companies |
| Lars Hugo Viking Rillner | Deputy Board Member | 0 companies |
| Stina Maria Selldén | Deputy Board Member | 0 companies |
| Sara Kristina Lundin | Deputy Board Member | 0 companies |
| Mikaela Jenni Berglund | Board of Directors | 0 companies |